Literature DB >> 3345495

Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma.

S E Singletary1, S L Tucker, A W Boddie.   

Abstract

In 135 patients with regional cutaneous recurrence of extremity melanoma, the prognostic significance of 12 clinical and pathologic variables was analyzed in four alternative Cox stepwise regression models and by single variable analysis. A highly significant fit of the regression (P less than 0.01) identified four factors that particularly influenced survival: the presence of intradermal or mixed (as opposed to purely subcutaneous) metastases (P less than 0.001), sex (P = 0.032), excision of regional cutaneous metastases with or without perfusion (P = 0.033), and the presence of subcutaneous metastases (P = 0.201). Not predictive of survival were age at diagnosis; site of primary; anatomic location, number, size, or distance from the primary of the regional cutaneous metastases; time since primary treatment; number of positive regional lymph nodes; and single- or triple-drug perfusion.

Entities:  

Mesh:

Year:  1988        PMID: 3345495     DOI: 10.1002/1097-0142(19880401)61:7<1437::aid-cncr2820610726>3.0.co;2-z

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

Review 1.  Current treatment of locoregional recurrence of melanoma.

Authors:  Malcolm Hart Squires; Keith A Delman
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

Review 2.  Surgery for Metastatic Melanoma: an Evolving Concept.

Authors:  Alessandro A E Testori; Stephanie A Blankenstein; Alexander C J van Akkooi
Journal:  Curr Oncol Rep       Date:  2019-11-06       Impact factor: 5.075

Review 3.  The changing prognosis of melanoma.

Authors:  A C Buzaid; C M Anderson
Journal:  Curr Oncol Rep       Date:  2000-07       Impact factor: 5.075

Review 4.  Regional therapies for in-transit disease.

Authors:  Paul J Speicher; Claire H Meriwether; Douglas S Tyler
Journal:  Surg Oncol Clin N Am       Date:  2015-01-30       Impact factor: 3.495

5.  Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis.

Authors:  Benjamin Weide; Christine Faller; Petra Büttner; Annette Pflugfelder; Ulrike Leiter; Thomas Kurt Eigentler; Jürgen Bauer; Andrea Forschner; Friedegund Meier; Claus Garbe
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

6.  Surgery of primary melanomas.

Authors:  Piotr Rutkowski; Marcin Zdzienicki; Zbigniew I Nowecki; Alexander C J Van Akkooi
Journal:  Cancers (Basel)       Date:  2010-05-11       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.